| μmol/L | micromoles per liter |
| 23Na MRI | sodium magnetic resonance imaging |
| ACE-I | angiotensin-converting enzyme inhibitor |
| AHRQ | Agency for Healthcare Research and Quality |
| AI | Adequate Intake |
| AMDR | Acceptable Macronutrient Distribution Range |
| AMSTAR | A Measurement Tool to Assess Systematic Reviews |
| ARB | angiotensin-receptor blocker |
| BMI | body mass index |
| CCHS | Canadian Community Health Survey |
| CDC | Centers for Disease Control and Prevention |
| CDRR | Chronic Disease Risk Reduction Intake |
| CI | confidence interval |
| CKD | chronic kidney disease |
| DASH | Dietary Approaches to Stop Hypertension |
| df | degrees of freedom |
| DNA | deoxyribonucleic acid |
| DoHAD | developmental origins of health and disease |
| DRI | Dietary Reference Intake |
| DRV | Dietary Reference Value |
| EAR | Estimated Average Requirement |
| EER | Estimated Energy Requirement |
| EFSA | European Food Safety Authority |
| FITS | Feeding Infants and Toddlers Study |
| FNDDS | Food and Nutrient Database for Dietary Studies |
| GRADE | Grading of Recommendations Assessment, Development and Evaluation |
| HDL | high-density lipoprotein |
| HIV | human immunodeficiency virus |
| HR | hazard ratio |
| IOM | Institute of Medicine |
| kg/m2 | kilograms per meter square |
| KHCO3 | potassium bicarbonate |
| LDL | low-density lipoprotein |
| LOAEL | lowest-observed-adverse-effect level |
| LVH | left ventricular hypertrophy |
| MD | mean difference |
| mg | milligrams |
| mg/d | milligrams per day |
| mg/L | milligrams per liter |
| mL | milliliters |
| mm Hg | millimeter of mercury |
| mmol | millimoles |
| mmol/d | millimoles per day |
| mmol/L | millimoles per liter |
| MSG | monosodium glutamate |
| NCI | National Cancer Institute |
| NDSR | Nutrition Data System for Research |
| NEAP | net endogenous acid production |
| NHANES | National Health and Nutrition Examination Survey |
| NHE3 | sodium hydrogen exchange 3 |
| OR | odds ratio |
| PAHO | Pan American Health Organization |
| PICO | population, intervention, comparator, and outcome |
| RAAS | renin-angiotensin-aldosterone system |
| RDA | Recommended Dietary Allowance |
| REML | restricted maximum likelihood |
| RR | risk ratio |
| SPRINT | Systolic Blood Pressure Intervention Trial |
| TOHP | Trials of Hypertension Prevention |
| TONE | Trial of Nonpharmacologic Interventions in the Elderly |
| UL | Tolerable Upper Intake Level |
| USDA | U.S. Department of Agriculture |
| WHI | Women’s Health Initiative |
| WIC | Special Supplemental Nutrition Program for Women, Infants, and Children |
This page intentionally left blank.